NeuroBo Pharmaceuticals announced the closing of a private placement and registered direct offering, as well as the dosing of the first patient in a Phase 1 clinical trial for a novel obesity treatment.
AI Assistant
METAVIA INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.